To establish "Golden Sea Bream" as an acceptable market name for Stenotomus chrysops.

119th Congress Introduced by Seth Magaziner

The bill allows labeling Stenotomus chrysops as “Golden Sea Bream” without violating the FD&C Act.

Introduced in House

Summary of HR 1832 — Golden Sea Bream Naming Clarification

Purpose and intent

HR 1832 would establish "Golden Sea Bream" as an acceptable market name for the fish species Stenotomus chrysops.

The core aim is to ensure that labeling or marketing this species under the name Golden Sea Bream is not considered misbranding or adulteration under the Federal Food, Drug, and Cosmetic Act (FD&C Act).

Key provisions

Introduced text (Version Content) provides the following specific provision:

A food shall not be treated as misbranded, adulterated, or otherwise in violation of the FD&C Act (21 U.S.C. 301 et seq.) because the food is labeled or marketed using the name Golden Sea Bream for the species Stenotomus chrysops.

In short, the bill adds a targeted exception to current labeling standards, clarifying that marketing Stenotomus chrysops as "Golden Sea Bream" is permissible and not a misbranding issue.

Affected parties and impact

Primary stakeholders: producers, processors, distributors, retailers, and marketers that handle Stenotomus chrysops.

Impact: Provides regulatory clarity and reduces risk of misbranding claims for products labeled as "Golden Sea Bream." May affect labeling practices, marketing materials, and consumer-facing product naming.

Scope is limited to labeling/marketing conduct under the FD&C Act; does not alter other labeling or safety requirements.

Procedural status and timeline

Introduced in the House on March 4, 2025.

Referred on the same day to the House Committee on Energy and Commerce.

Sponsor: Seth Magaziner (primary).

Legislative process and next steps

As of introduction, the bill is in the early stage of the legislative process. It must pass the committee (Energy and Commerce) before moving to the House floor for a vote.

Potential discussions may address implementation details, any overlap with existing labeling rules for seafood, enforcement considerations, and any related labeling guidance from the FDA.

Context and considerations

The bill focuses on a nomenclature issue, not on species classification, safety standards, or fisheries management.

Questions for further consideration (if advanced): How this interacts with other market names internationally, any potential consumer confusion with other “sea bream” species, and whether similar clarifications might be needed for other common names.